Optimal Management of Public Perceptions During A Flu Outbreak: A Game-Theoretic Perspective.
Evolutionary game theory
Free-riding behaviour
Herd immunity
Pontryagin’s maximum principle
SIR model
Vaccination
Journal
Bulletin of mathematical biology
ISSN: 1522-9602
Titre abrégé: Bull Math Biol
Pays: United States
ID NLM: 0401404
Informations de publication
Date de publication:
16 10 2020
16 10 2020
Historique:
received:
24
09
2019
accepted:
02
10
2020
entrez:
16
10
2020
pubmed:
17
10
2020
medline:
10
2
2022
Statut:
epublish
Résumé
Public perceptions and sentiments play a crucial role in the success of vaccine uptake in the community. While vaccines have proven to be the best preventive method to combat the flu, the attitude and knowledge about vaccines are a major hindrance to higher uptake in most of the countries. The yearly coverage, especially in the vulnerable groups in the population, often remains below the herd immunity level despite the Flu Awareness Campaign organized by WHO every year worldwide. This brings immense challenges to the nation's public health protection agency for strategic decision-making in controlling the flu outbreak every year. To understand the impact of public perceptions and vaccination decisions while designing optimal immunization policy, we model the individual decision-making as a two-strategy pairwise contest game, where pay-off is considered as a function of public health effort for the campaign. We use Pontryagin's maximum principle to identify the best possible strategy for public health to implement vaccination and reduce infection at a minimum cost. Our optimal analysis shows that the cost of public health initiatives is qualitatively and quantitatively different under different public perceptions and attitudes towards vaccinations. When individual risk perception evolves with vaccine uptake or disease induced death, our model demonstrates a feed-forward mechanism in the dynamics of vaccination and exhibits an increase in vaccine uptake. Using numerical simulation, we also observe that the optimal cost can be minimized by putting the effort in the beginning and later part of the outbreak rather than during the peak. It confers that public health efforts towards disseminating disease severity or actual vaccination risk might accelerate the vaccination coverage and mitigate the infection faster.
Identifiants
pubmed: 33064223
doi: 10.1007/s11538-020-00817-9
pii: 10.1007/s11538-020-00817-9
pmc: PMC7563916
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
139Références
BMC Infect Dis. 2011 Apr 07;11:87
pubmed: 21473763
Theor Popul Biol. 2007 May;71(3):301-17
pubmed: 17335862
BMC Public Health. 2011 Feb 25;11 Suppl 1:S5
pubmed: 21356134
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Clin Infect Dis. 2006 Dec 1;43(11):1379-86
pubmed: 17083008
J Theor Biol. 2019 Jun 7;470:108-118
pubmed: 30904449
Proc Biol Sci. 2005 Aug 22;272(1573):1669-75
pubmed: 16087421
PLoS Med. 2013 Oct;10(10):e1001527
pubmed: 24115913
J Theor Biol. 2005 May 21;234(2):201-12
pubmed: 15757679
Arch Intern Med. 2005 Feb 14;165(3):265-72
pubmed: 15710788
Math Biosci Eng. 2009 Jul;6(3):469-92
pubmed: 19566121
Bull Math Biol. 2012 Apr;74(4):958-80
pubmed: 22147102
Vaccine. 2011 Jul 26;29(33):5519-25
pubmed: 21601606
BMC Public Health. 2011 Feb 25;11 Suppl 1:S11
pubmed: 21356130
N Engl J Med. 1994 Sep 22;331(12):778-84
pubmed: 8065407
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10564-7
pubmed: 12920181
BMC Infect Dis. 2010 Apr 19;10:99
pubmed: 20403201
PLoS Comput Biol. 2012;8(4):e1002452
pubmed: 22496631
Vaccine. 2003 May 1;21(16):1776-9
pubmed: 12686093
PLoS Curr. 2009 Dec 09;1:RRN1134
pubmed: 20033093
Int J Environ Res Public Health. 2010 Mar;7(3):853-69
pubmed: 20617008
SIAM J Appl Math. 2014;74(6):1810-1830
pubmed: 25878365
Arch Intern Med. 2008 Dec 8;168(22):2405-14
pubmed: 19064822
Psychol Health. 2012;27(1):101-15
pubmed: 21736427
Vaccine. 2015 Apr 8;33(15):1802-7
pubmed: 25744225
Math Biosci Eng. 2011 Jan;8(1):113-22
pubmed: 21361403
Vaccine. 2012 Jul 6;30(32):4785-9
pubmed: 22633868
JAMA. 2009 Nov 4;302(17):1896-902
pubmed: 19887665
Hum Vaccin Immunother. 2012 Jun;8(6):842-4
pubmed: 22832255
PLoS One. 2012;7(10):e45653
pubmed: 23049682
Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5692-7
pubmed: 17369367
Math Biosci. 2006 Dec;204(2):185-98
pubmed: 17056073
PLoS One. 2010 Sep 15;5(9):e12594
pubmed: 20856798
PLoS One. 2010 Nov 11;5(11):e13767
pubmed: 21085686
Vaccine. 2007 Sep 28;25(39-40):6852-62
pubmed: 17719149
Math Biosci. 2011 Apr;230(2):67-78
pubmed: 21277314
Lancet Infect Dis. 2018 Nov;18(11):1191-1210
pubmed: 30243584
PLoS One. 2010 May 06;5(5):e10520
pubmed: 20463898
Epidemiol Infect. 2007 Oct;135(7):1109-16
pubmed: 17306052
Nature. 2006 Jul 27;442(7101):448-52
pubmed: 16642006
PLoS Comput Biol. 2010 May 27;6(5):e1000793
pubmed: 20523740
Am J Epidemiol. 2009 Sep 15;170(6):679-86
pubmed: 19679750
Vaccine. 2015 Jun 4;33(24):2741-56
pubmed: 25936726
BMJ. 2009 Dec 10;339:b5213
pubmed: 20007665
PLoS Med. 2006 Apr;3(4):e89
pubmed: 16509764
BMC Public Health. 2018 Sep 20;18(1):1131
pubmed: 30236092
Hum Vaccin Immunother. 2018 Apr 3;14(4):952-957
pubmed: 29333939
Math Biosci Eng. 2013 Oct-Dec;10(5-6):1615-34
pubmed: 24245639
Bull World Health Organ. 2012 Apr 1;90(4):252-3
pubmed: 22511819
Vaccine. 2012 May 14;30(23):3459-62
pubmed: 22446636
J Theor Biol. 2011 Mar 21;273(1):63-71
pubmed: 21187103